EGFR-TK-IN-6
EGFR-TK-IN-6 is an EGFR-TK inhibitor (IC50 = 0.65 μM) . EGFR-TK-IN-6 has anti proliferative activity against MCF-7 cells (IC50 = 37.7 μM) . EGFR-TK-IN-6 has low toxicity to normal cells. EGFR-TK-IN-6 can be used for cancer research[1].
Product Specifications
UNSPSC
12352005
Target
EGFR; Tyrosinase
Related Pathways
JAK/STAT Signaling; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C1NC(C([C@@H](NCC)C2=CC=CC=C2)=C(N)N1)=O
Molecular Formula
C13H16N4O2
Molecular Weight
260.29
References & Citations
[1]Shehta W, et al. Synthesis, in silico and in vitro studies of aminopyrimidine hybrids as EGFR TK inhibitors and anti-proliferative agents. RSC Adv. 2025 Oct 6;15 (44) :36895-36906.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470352-100 1x 100 µL
CD31 / PECAM-1 (158-2B3), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680633-100 1x 100 µL
Von Willebrand Factor (3E2D10), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880017-100 1x 100 µL
Ep-CAM / CD326 (VU-1D9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940172-100 1x 100 µL
CD45 / LCA (135-4C5), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details